Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antigen Rapid Test Screening to Prevent SARS-CoV-2 Transmission at Mass Gathering Events. A Randomised Trial.

NCT04898127 is registered in ClinicalTrials.gov with Norwegian Institute of Public Health as lead sponsor.

NCT NCT04898127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04898127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antigen Rapid Test Screening to Prevent SARS-CoV-2 Transmission at Mass Gathering Events. A Randomised Trial.
Lead sponsor
Norwegian Institute of Public Health
Phase
Not applicable
Overall status
Withdrawn
Start date
May 31, 2021
Completion date
December 31, 2021
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid19